Show Search Form
human indexable | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||
registered interest | |||||||||||
answer date | |||||||||||
date | |||||||||||
date tabled | |||||||||||
ddp created | |||||||||||
answering body |
|
||||||||||
question status | Tabled | ||||||||||
answering dept id | 20 | ||||||||||
answering dept short name | International Development | ||||||||||
answering dept sort name | International Development | ||||||||||
ddp modified |
|
||||||||||
hansard heading | Antimicrobials: Drug Resistance | ||||||||||
house id | 2 | ||||||||||
identifier | HL16012 | ||||||||||
legislature |
|
||||||||||
parliament number | 57 | ||||||||||
question first answered |
|
||||||||||
question text | To ask Her Majesty's Government what assessment they have made of how the forthcoming replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria could contribute to delivering on the UK's five-year national action plan on tackling antimicrobial resistance 2019–2024. | ||||||||||
session |
|
||||||||||
session number | 1 | ||||||||||
tabling member printed |
|
||||||||||
title | House of Lords Tabled Parliamentary Question 2017/19 HL16012 | ||||||||||
type |
|
||||||||||
uin | HL16012 | ||||||||||
version | 2 | ||||||||||
written parliamentary question type | Ordinary | ||||||||||
answer |
|
||||||||||
creator |
|
||||||||||
publisher | 25277 | ||||||||||
tabling member |
|